ureteral obstruction (UUO) is driven by increased levels of angiotensin II (Ang II). In this study, we examined the time course of the fibrotic process in rats with UUO and explored the effect of delayed administration of an angiotensin converting enzyme (ACE) inhibitor, enalapril, on the tubulointerstitial fibrosis of obstructive uropathy. Rats were sacrificed at 3, 5, 8, or 10 days after UUO was initiated. Some rats did not receive treatment, whereas others were treated with enalapril from day 4 to day 8 or from day 6 to day 10 after the Onset of UUO. The levels of mRNA for transforming growth factor I3 (TGF-/31), collagen type IV (collagen IV), and tissue inhibitor of metalloproteinase (TIMP-1) were measured at each time point by reverse transcription-polymerase chain reaction (RT-PCR). The relative volume of the tubulointerstitium (Vv) was measured by a pointcounting method. Monocyte/macrophage infiltration and collagen IV protein deposition were examined histologically using specific antibodies. There were significant increases in TGF-f31, TIMP-1, and collagen IV mRNAs in the obstructed kidney. Treatment with enalapril on day 4 through day 8 or on day 6 through day 10 significantly reduced the elevated mRNA levels of these compounds in the obstructed kidney.
Histological studies showed augmented Vv, monocyte/macrophage infiltration, interstitial cr-smooth muscle actin expression, and collagen IV protein deposition on days 3, 5, 8, or 10 of UUO; enalapril treatment from day 4 to 8 or from day 6 to 10 halted and to an extent reversed these increases. These data suggest that enalapril administration after several days of UUO is an effective means of preventing the progression of tubulointerstitial fibrosis of obstructive uropathy.
Tubulointerstitial fibrosis is the major histopathological change in several models of experimental renal disease [1] [2] [3] [4] [5] [6] . Unilateral ureteral obstruction (UUO) is a model of experimental renal injury characterized by progressive tubulointerstitial fibrosis [5] [6] [7] [8] [9] [10] . Acute or chronic ureteral obstruction occurs in a variety of clinical settings (congenital hydronephrosis, tumor, calculus, benign prostatic hypertrophy, trauma, pregnancy, etc.) [11] . Individuals with chronic obstructive uropathy may progress to end-stage renal disease [12] . Although relief of the obstruction is the therapeutic option of choice [11] , this may not always be feasible and other therapeutic modalities need to be developed to reverse or halt the eventual progression of the renal disease that occurs as a consequence of obstructive uropathy. quent deposition of collagen [6] . Since these alterations are prevented to a large extent by the prior or concomitant administration of an angiotensin converting enzyme (ACE) inhibitor or a specific angiotensin II (Ang II) receptor antagonist [6, 14] , it is clear that Ang II has a critical role in the overall process of tubulointerstitial fibrosis through an increase in TGF-J31. However, it is not known if interrupting Ang II generation after the onset of obstructive uropathy will alter the progression of tubulointerstitial fibrosis.
The mechanisms of progression of tubulointerstitial fibrosis have not been completely elucidated. TGF-pl modulates the synthesis of extracellular matrix components including collagen IV by increasing matrix protein mRNA levels, inhibits the production of metalloproteinases and also increases the production of metalloproteinase inhibitors [15] . All these factors and the proliferation of interstitial fibroblasts and infiltration of the renal parenchyma by monocytes/macrophages promote the development of tubulointerstitial fibrosis. The purpose of this study was to examine the temporal relationship of factors underlying the development of tubulointerstitial fibrosis in rats with UUO and to explore the potential effect of the ACE inhibitor enalapril administered after tubulointerstitial fibrosis is already present.
Methods

Animals and experimental protocol
Female Sprague-Dawley rats (Harlan Bioproducts, Indianapolis, IN, USA) weighing 180 to 228 g were used in these experiments. Most of the rats underwent unilateral ureteral obstruction (UUO) as described previously [6, 13] . Under halothane anesthesia the left ureter was ligated with 4-0 silk at two points and cut between the ligatures. Control rats (N = 5), also referred to as normal rats, underwent no surgical manipulation while 3 rats underwent sham operations in which the left ureter was manipulated but not ligated. All animals were fed a standard rat chow and given tap water ad libitum; rats with UUO were sacrificed under pentobarbital anesthesia (5.0 mg/kg body wt) given intraperitoneally after three days (N = 7), five days (N = 8), eight days (N = 8) or 10 days (N = 5) of UUO. Eight animals were administered the ACE inhibitor enalapril in the drinking water (200 mg/liter) subsequent to obstruction, from day 4 to day 8, and then sacrificed on day 8, while 5 rats were treated with the ACE inhibitor from day 6 to day 10 and then sacrificed on day 10.
Tissue preparation and RNA extraction For histological studies three to five animals from each group (as defined by the duration of the UUO) were anesthetized with pentobarhital. Their kidneys were perfused in vivo with cold Hank's balanced salt solution (HBSS), pH 7.2, and then with a tissue fixative (Histochoice, Amresco, Solon, OH, USA) for 10 minutes. The kidneys were removed, sliced axially in 3-mm thick sections, immersed in the same fixative for four hours at 4°C, washed with HBSS and embedded in paraffin. Paraffin sections, 4 jiM in thickness, were subjected to Azan-Mallory staining or immunochemical analysis.
For RNA extraction, kidneys of the rest of the animals in each group were perfused in situ with cold HBSS. In some of these animals an axial slice, 2 mm thick, was immersed in Histochoice for histological evaluation. We have observed no obvious differences between samples fixed in Histochoice and those fixed in situ. The remaining renal cortex was dissected immediately and minced in cold RNAzol (Cinna/Bioteck, Houston, TX, USA). Total RNA was extracted using the guanidinium isothiocyanatc (RNAzo1) method [161. The total RNA was dissolved in RNAse-free water (Sigma, St. Louis, MO, USA) and quantitated precisely by UV speetrophotometry at 260 nm and 280 nm. RNA with an 0D2601280 ratio greater than 1.9 was used for eDNA synthesis.
Immunohistochemical studies and morphometric analysis The deparaffinized sections were washed in phosphate buffered saline (PBS) for 10 minutes each of three times, preincubated in blocking solution (10% goat or rabbit serum in PBS) for 30 minutes, washed in PBS three times and then incubated with primary antibody in PBS for two hours at room temperature.
Mouse A standard point counting method was used to quantitate the volume of the renal cortex occupied by interstitium, tubules, glomeruli and fluid space (tubular lumen and Bowman's space) [171. The relative volume (Vv) of the renal cortical interstitium was determined on sections using the Azan-Mallory method to stain collagen fibers in tubular basement membrane (TBM), glomeruli, and interstitial space, as described previously [6, 13, 14] . One point count study evaluated interstitium only and was based on 1170 points for each kidney. Another point count study was performed to evaluate the interstitium, tubule, glomerular and fluid space volume. For this study, fields containing only one glomerulus were counted and 100 points in six different fields within each kidney were evaluated.
The matrix score for collagen IV and a-smooth muscle expression in the renal cortical interstitium was determined as described previously [6, 14] . Twenty random, non-overlapping fields of sections stained for collagen IV were assigned a score of zero to three (a score of zero was equivalent to the results in a normal kidney). Progressively higher scores were assigned depending on the degree and amount of interstitium that reacted with the antibodies specific for collagen IV or a-smooth muscle actin. The scores of the twenty fields of each kidney were averaged. The average scores of samples from three separate animals were then averaged.
Characterization and quantitation of TGF-f31, TJMP-1, and collagen a(IV) mRNA by reverse transcription-polymerase chain reaction (RT-PCR)
Oligo dT primed first strand eDNA was synthesized with a eDNA cycle kit from Promega (Madison, WI, USA) using 2 jig of total RNA for TGF-f31 and TIMP-1, and 4 jig for collagen IV. The mixture of total RNA (2 jig or 4 j.tg/10 jil RNAse-free water) and oligo dT (1 j.tl) was incubated at 65°C for 10 minutes to denature the secondary structure and chilled on ice immediately. The resulting mixture was incubated at 42°C for one hour after adding 5 units of avian myeloblastic virus transcriptase, heated to 94°C for five minutes and chilled on ice. A second round of reverse transcription was performed after adding 5 units of enzyme.
Polymerase chain reaction (PCR) was performed using 3 jil of each eDNA incubation. Amplification was done in a total volume of 50 jil containing PCR buffer (50 mM KCI, 10 mM Tris-HCI), 1. In order to quantitate PCR products and to confirm the integrity of the RNAs we coamplified a housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in companion tubes. We used a small amount (1 pi) of eDNA from the cortex with 25 pmol of primers to ampli' the GAPDH message. The TGF-/31 primers were designed from the sequence of the rat gene:
5'-AATACGTCAGACATI'CGGGAAGCA (sense) from exon 2 and 3' -GTCAATGTACAGCTGCCGTACACA (antisense) from exon 6 to yield a 498 bp product [18] . The TIMP-1 primers were designed from the sequence of the murine gene: 5'-GACCTG-GTCATAAGGGCTAAA (sense) and S '-GCCCGTGATGAGA-AACTCTT'CACT (antisense) to yield a 216 bp product [19] . The collagen al(IV) primers were designed from the sequence of the murine gene: 5' -GTGCGGTTTGTGAAGCACCG (sense) and 3'-GTFCTTCTCATGCACACTT (antisense) to yield a 363 bp product [20] . The GAPDH primers were designed from the sequence of the rat gene: 5'-AATGCATCCTGCACCACCAA (sense) and 3 '-GTAGCCATATTCA'flTGTCATA (antisense) to yield a 515 bp product [21] . PCR was performed with a Perkin Elmer Cetus DNA Thermal Cycler using the following program: Effect of delayed enalapril treatment on the histology of the kidney cortex of rats with ureteral obstruction. Shown are representative sections of kidney from untreated rats three days after obstruction (A) and eight days after obstruction (B) and from rats treated with enalapril from day 4 to day 8 after the onset of obstruction (C). Also shown are representative sections of kidney from untreated rats five days after obstruction (D) and 10 days after obstruction (E) and from rats treated with enalapril from day 6 to day 10 after the onset of obstruction (F). PCR products were quantitatively analyzed as described previously [6, 13, 14] . After amplification, 15 1.d of each PCR reaction mix was electrophoresed through a 1.2% agarose gel with ethidium bromide (0.5 tg/ml). The gel was photographed with Polaroid Type 665 positive/negative film (Polaroid Corporation, Cambridge, MA, USA) over UV light at the same exposure and development time for all gels photographed. The bands on the negative film were scanned by densitometry (Sepra Scan 20001 software, Integrated Separation System, Natwick, MA, USA) for quantitation. The PCR products of TGF-pl and GAPDH, TIMP-1 and GAPDH, or collagen IV and GAPDH (those amplified from the same cDNA) were electrophoresed in the same gel and ratios for TGF-131/GAPDH, TIMP-1/GAPDH, or collagen IV/GAPDH were determined to eliminate gel-to-gel or film-to-film variance.
Statistical analysis
Data, shown as mean SD, were analyzed by unpaired I-test on the Macintosh Stat View program. Comparison between values for the contralateral kidney and obstructed kidney were performed using a paired t-test. ANOVA was employed to determine the significance of the relative volume of the renal interstitium (Vv), ED-I positive cell infiltration, a-smooth muscle actin matrix score, and collagen IV matrix score.
Results
Morphometric analysis
Microscopic sections obtained from the experimental kidney of animals three days after the onset of obstruction revealed a slightly expanded interstitium and a cellular infiltrate (Fig. 1A) . The experimental kidney of rats with ureteral obstruction of eight days duration had a greatly expanded interstitium, which was occupied by many cellular elements (Fig. 1B) . The obstructed kidney of rats treated from day 4 to day 8 with enalapril had a modest increase of interstitial cellularity (Fig. IC) above that seen on day 3 in those animals (Fig. 1A) , but not to the extent seen on day 8 (Fig. 1B) in animals not receiving enalapril.
Examination of sections obtained from the obstructed kidney after five days or 10 days of ureteral obstruction revealed a greatly expanded interstitium with a considerable amount of cellularity ( Fig. 1 D and E, respectively) . In the obstructed kidney of rats treated from day 6 to 10 with enalapril there was a decrease in cellularity in many areas (Fig. lF) . Some areas of the obstructed kidney treated from day 6 to 10 did, however, contain a hypercellular intcrstitium (Fig. iF) .
The relative volume of the cortical interstitium was expressed as the volume fraction (Vv) (Fig. 2A) . The Vv of the obstructed kidney was significantly increased (P < 0.01) at three and eight days of obstruction. After three days of obstruction, Vv was 17.2 2% and 8 1% in the obstructed kidney and contralateral kidney, respectively; at eight days of obstruction, Vv was 41. 8 5.1% and 9
1.8% in the obstructed kidney and contralateral kidney, respectively. Administration of enalapril from days 4 through 8 after the onset of obstruction resulted in a significantly lesser increase in the interstitial volume, to 25.8 3.4%, than was seen in the obstructed kidney of untreated rats (P < 0.01). No significant difference was detected in the Vv of the contralateral kidney between days 3 and 8 in rats with UUO, and there were no differences in the contralateral kidney between untreated and enalapril treated animals at day 8. The Vv of the contralateral kidney in each group was not significantly different from that measured in the kidneys of sham-operated rats (9.7 1.2, N = 3; Fig. 2A) .
The Vv of the obstructed kidney at five days (38.7 1.5) and 10 days (43.3 4.6) of UUO was not significantly different from that of the obstructed kidney of rats with UUO of eight days duration (compare Fig. 2 A and B) . The standard deviations after 8 or 10 days of obstruction for Vv measurements were considerably increased compared to that of day 5 measurements due to the variability in the widening of the interstitium beyond day 5. Treatment with enalapril from day 6 to day 10, however, resulted in a Vv of 32.3 4.9% in the obstructed kidney. This is significantly less than the Vv of the obstructed kidney of untreated rats at either day 5 (P < 0.05) or at day 10 (P < 0.01). The Vv of the contralateral kidney of rats with UUO was not significantly different from that of the kidneys of 8-day sham-operated rats ( Fig. 2A) .
In a smaller point count study using three different animals under each condition, we evaluated the amount of cortical volume occupied by interstitium, tubules, glomeruli, and the fluid space (Table 1 ). This study indicates that the volume occupied by glomeruli did not significantly change over the 10-day duration of UUO or with enalapril treatment. With the exception of the levels measured on day 3 of UUO, the fluid volume (lumen plus Bowman's space) was not significantly changed ( Table 1) . As the volume of cortex occupied by interstitium significantly increased there was a reciprocol significant decrease in the volume occupied by tubules (Table 1) .
Monocyte/macrophage infiltration of the kidney during UUO Figure 3A ). There were no significant changes in the number of ED-i positive cells in the contralateral kidney of all three groups of rats with unilateral ureteral obstruction from that seen in the kidneys of sham-operated rats. Figure 3B shows that the number of ED-i positive monocytes/ macrophages in the obstructed kidney at day 10 of UUO (83.9 5.1 cells per field) is significantly increased over the number found at day 5 of UUO (67. the animals treated from days 6 to 10 with the ACE inhibitor is significantly less than that of obstructed kidney from untreated animals at day 5 after obstruction was initiated (P < 0.05).
that seen on day 5, prior to initiating treatment with the ACE inhibitor (Fig. 3B) . As was seen with the Vv, the SD of the infiltrate measurements was increased due to the somewhat focal nature of the infiltrate measured in different microscopic fields of the same histologic section.
Immunohistochemical studies on collagen IV and a-smooth muscle actin We have shown previously a progressive increase in collagen IV protein in the interstitium of the obstructed kidney [6, 141. The up-regulation of collagen IV protein in the renal cortex and the impact of delayed treatment with the ACE inhibitor on this process was assessed using the matrix score technique [6, 14] . Table 2 illustrates that between day 3 and 8 of UUO there was a significant increase in the collagen IV content of the interstitium. Treating animals with enalapril on day 4 through day 8 of UUO untreated dp < 0.05, 10 day obstructed treated compared to 10 day obstructed untreated P < 0.04, 3 day obstructed compared to all other conditions effectively limited the increase in interstitial protein deposition to a value not significantly different from that seen after three days of obstruction. The matrix score of the sham-operated kidneys was zero.
The matrix score for collagen IV in the obstructed kidney of rats after 10 days of continuous UUO without treatment was significantly different from that found at day 5 of UUO (Table 2) . There was a slight increase from the score seen at day 8 of UUO (Table 2 ). Enalapril treatment initiated at day 6 of UUO significantly retarded the increase in collagen IV within the matrix and reduced the matrix collagen IV content to below that seen at day 5 of UUO.
We have also previously shown that a-smooth muscle actin is expressed by interstitial cells of the obstructed kidney [14] . As shown in Table 3 , there is a marked increase in the a-smooth muscle actin matrix score between day 3 and dayS of UUO. There is no marked change in the matrix score for a-smooth muscle actin between days 5, 8, and 10 of continuous untreated UUO. Enalapril treatment initiated on day 4 of UUO significantly blunted the increase in matrix score at day 8. There was a significant reversal (decrease) in the a-smooth muscle actin matrix score when enalapril treatment was initiated on day 6 and the animals sacrificed on day 10 of UUO (Table 3) .
Time course expression of TGF-pl mRNA, TIMP-1 mRNA and collagen IV mRNA during UUO As reported previously [6, 13, 14] , the obstructed kidney of untreated rats with UUO showed a prominent increase in TGF-/31 mRNA levels as compared to the contralateral kidney of the same rats or kidneys of sham operated or normal animals at each time point (Fig. 4) . Treatment with enalapril on day 4 through day 8 or from day 6 to day 10 after UUO significantly limited the increased expression of TGF-/31 mRNA both in the obstructed kidney and in the contralateral kidney. The time course of changes in TIMP-1 mRNA in the rats with UUO resembled that of TGF-pl (Fig. 5) . A significant difference between the obstructed kidney and the normal or sham-operated kidneys was detected at each time point and the obstructed kidney at day 10 showed a 3.8-fold increase over "normal" values. The contralateral kidney showed a significant increase as compared to "normal" kidneys at each time point. Enalapril treatment on day 4 through day 8 or day 6 through day 10 significantly blunted the increased expression of TIMP-i mRNA both in the obstructed kidney and in the contralateral kidney.
Like TGF-/31 mRNA and TIMP-1 mRNA, collagen IV mRNA levels in the obstructed kidney of untreated rats with UUO increased steadily with time (Fig. 6) . Administration of enalapril from day 4 through day 8 or from day 6 through day 10 This ultimately leads to "destruction" of both glomeruli and tubules of the experimental kidney [5, 11] .
The renin-angiotensin system (RAS) is up-regulated in rats with UUO within 24 hours of obstruction [25, 26] . It is highly likely that the development and progression of tubulointerstitial fibrosis in rats with UUO is related to increased levels of angiotensin H in the experimental kidney [6, 14] . In previous studies, we found that inhibition of Ang II formation prior to or concomitant with the onset of ureteral obstruction ameliorated 
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Values are the mean so of 3 different animals and represent the percent of time that each of the 20 fields was assessed that score. C P < 0.03 compared to day 3, untreated "P < 0.05 compared to day 8 or day 10, untreated the leukocyte influx, the hemodynamic events, and the severity of tubulointerstitial fibrosis in this model. In the present study we inhibited angiotensin II formation after UUO was established and a significant degree of tubulointerstitial fibrosis had occurred, Delayed administration of an ACE inhibitor slowed if not halted the progression of the tubulointerstitial fibrosis in the experimental kidney of rats with unilateral ureteral obstruction.
At present we do not know how extensively fibrosis of the interstitium can progress before ACE treatment would become ineffective. Indeed, as shown in Figure 1 and from the wider standard deviations shown in Figures 2 and 3 , there is considerable variation within the span of one 200x microscope field. The overall picture is that treatment with enalapril does effectively decrease the cellularity within the interstitium during both treatment regimes. A corollary to that generalization, however, is that delaying treatment until day 6 is not quite as effective as beginning it on day 4. Interestingly, previous studies in an experimental model of glomerulosclerosis reported that glomeruli in an ad- vanced stage of sclerosis were refractory to treatment with an ACE inhibitor [27, 28] , unlike glomeruli with early histologic signs of sclerosis.
In the present study we found that the increase in the fractional volume of the kidney cortex occupied by interstitium was balanced by a decrease in the fractional volume occupied by the tubules. This reciprocal relationship of interstitium and tubules was also seen in the development of cyclosporine nephropathy and treatment with ACE inhibitor [291. During uretcral obstruction the size of the kidney increases in rats. Therefore, as the interstitium expands with proliferating fibroblasts and matrix protein deposition the tubules are pushed apart and displaced from each other and from peritubular capillaries. These observations in the rat are consistent with ultrastructural changes observed in human chronic hydronephrosis [17] .
Although we gave relatively high doses of enalapril (200 mg/liter in the drinking water, 30 mg/kg/day equivalent), which undoubtedly decreased the blood pressure of the animals, results of a previous study indicate that the beneficial effect of ACE inhibitors in tubulointerstitial fibrosis is by and large independent of their effect on blood pressure [141. A previous study concerning glomeruloselerosis indicated that ACE inhibition had a beneficial effect beyond that needed to reduce blood pressure [27] . It is also worth noting that in this study the enalapril treated animals drank the same amount of water and appeared to consume the same amount of food as the untreated animals. Therefore the nutritional status of the treated animals was no different from that of the untreated animals. The eventual increase in collagen IV protein deposition is due to the increase in the mRNA for the protein and a presumed increase in TIMP-1. Diamond et al [30] and Sharma et al [311 have suggested that infiltrating macrophages are the source of TGF-f31, and that macrophages and TGF-f31 regulate TIMP-1 gene expression and the subsequent accumulation of collagen IV [26, 31] . In the present study TGF-/31 mRNA and TIMP-1 mRNA changed in parallel. Whether macrophages are the source of TGF-/31 in the obstructed kidney of rats with UUO remains to be determined. Of note in our study is the fact that the interstitial volume, TGF-p1 mRNA, TIMP-1 mRNA and a-smooth muscle actin expression were significantly less at day 10 of obstruction in the rats treated with enalapril as compared to the levels found at day 5 of ureteral obstruction in untreated animals. This suggests that a reversal of some of the elements responsible for fibrosis had occurred. A myofibroblast phenotype develops in the interstitium [8, 14] and may be a sensitive indicator of the driving forces for fibrosis of the interstitium. The changes in mRNA levels in the contralateral kidney of rats with UUO (see Results) are noteworthy. Sharma et al examined cortical interstitial volume fraction and collagen IV mRNA in rabbits with UUO for 16 days and reported no significant difference in these two factors between the contralateral kidney and the kidneys of sham-operated animals [10] . Similar findings occurred when measuring TIMP-1 mRNA [311. Diamond and coworkers studied TGF-/31 mRNA levels in the four days following the initiation of UUO in rats; kidney sections were stained immunohistologically using anti TGF-j31 antibody. There was neither a significant increase in TGF-f31 mRNA nor TGF-131 positive staining in the contralateral kidney [301. It is possible that Northern blot analysis, used in that study, is not as sensitive as the RT-PCR we describe in the present report. Although histologically we could not detect significant increases of Vv, collagen IV, matrix score, and ED-i positive monocytes/macrophages in the contralateral kidney even at day 10 of obstruction, the contralateral kidney demonstrated a 2.8-fold increment in TGF-/31 mRNA, a 2.4-fold increment in TIMP-1 mRNA, and a 1.7-fold increase in collagen IV mRNA, respectively, whereas there were no such increases in kidneys of sham-operated rats. In a biochemical study of rats with UUO hydroxyproline incorporation into the contralateral kidney was increased about sixfold over that of the normal kidney at 15 days of UUO [32] . In the same study collagenolytic activity was decreased by 20%. This correlates with our studies, suggesting that molecular mechanisms in the contralateral kidney are posed for increasing collagen synthesis.
Our experimental data suggest that ACE inhibitors may be a possible pharmacotherapeutic intervention in patients with obstructive nephropathy. In the present study we specifically documented changes in the levels of TIMP-1 mRNA in kidney tissue. TIMP-1 is by definition an inhibitor of metalloproteinases, and as such would normally degrade excess matrix protein [15] . For a therapeutic process to effectively resolve established fibrotic processes in the kidney, an increase in metalloproteinase activity is as necessary as a decrease in the synthesis of matrix proteins.
Enalapril effectively decreased TIMP-1 mRNA levels or at least prevented them from increasing. This in turn would result in increased collagenolytic activity and lead to a decrease in the total amount of collagen present in the interstitium. The collagenolytic activity of the obstructed kidney is decreased by 90% at 15 days of UUO [32] .
In summary, this study reports the time course of tubulointerstitial fibrosis in the setting of UUO. The Vv, collagen IV, a-smooth muscle actin, and monocyte/macrophage content of the interstitium in the obstructed kidney of rats with UUO increased with time. Administration of enalapril until three or five days after UUO was initiated largely prevented the progression of tubulointerstitial fibrosis in rats with UUO beyond that already present when enalapril was begun. This observation has therapeutic implications as to the possible use of ACE inhibitors in patients with obstructive nephropathy.
